Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin for acute hepatic encephalopathy in cirrhosis
2008-003376-21Phase 4Completed
- Sponsor
- Vall d'Hebron University Hospital
- Start
- Aug 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-blind trial of albumin (human) in hepatic encephalopathy (HE) and Cirrhosis, sponsored by Vall d'Hebron University Hospital. Primary endpoints: Grade of hepatic encephalopathy on day 4 and Resolution of hepatic encephalopathy signs by day 4. Started Aug 2008; status: completed.
02
Drugs
albumin (human)
03
Conditions
hepatic encephalopathy (HE)Cirrhosis
Beyond the preview
Go deeper on 2008-003376-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003376-21.